D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II
Glutamate carboxypeptidase-II (GCPII) is a zinc-dependent metalloenzyme implicated in numerous neurological disorders. The pharmacophoric requirements of active-site GCPII inhibitors makes them highly charged, manifesting poor pharmacokinetic (PK) properties. Herein, we describe the discovery and ch...
Saved in:
Main Authors: | Sadakatali S. Gori (Author), Ajit G. Thomas (Author), Arindom Pal (Author), Robyn Wiseman (Author), Dana V. Ferraris (Author), Run-duo Gao (Author), Ying Wu (Author), Jesse Alt (Author), Takashi Tsukamoto (Author), Barbara S. Slusher (Author), Rana Rais (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitor
by: Kai Tang, et al.
Published: (2024) -
A glutamate concentration‐biased allosteric modulator potentiates NMDA‐induced ion influx in neurons
by: Blaise M. Costa, et al.
Published: (2021) -
In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5
by: Sarah Beggiato, et al.
Published: (2018) -
Prolyl carboxypeptidase in Agouti-related Peptide neurons modulates food intake and body weight
by: Giuseppe Bruschetta, et al.
Published: (2018) -
Discovery of potent allosteric antibodies inhibiting EGFR
by: Léxane Fournier, et al.
Published: (2024)